Full Text View
Tabular View
No Study Results Posted
Related Studies
Exemestane in Treating Postmenopausal Women at High Risk for Invasive Breast Cancer
This study is currently recruiting participants.
Study NCT00085072   Information provided by National Cancer Institute (NCI)
First Received: June 10, 2004   Last Updated: July 7, 2009   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Breast Cancer
Precancerous/Nonmalignant Condition
Additional conditions recognized in this trial
Breast Neoplasms
Precancerous Conditions
More general conditions related to this trial
Breast Diseases
Neoplasms
Neoplasms by Site
Skin Diseases
Interventions listed in this trial
exemestane
More general drug interventions related to this trial
Antineoplastic Agents
Aromatase Inhibitors
Enzyme Inhibitors
Molecular Mechanisms of Pharmacological Action
Pharmacologic Actions
Therapeutic Uses
Sponsors listed in this trial
Lombardi Cancer Research Center
National Cancer Institute (NCI)


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services